Malaria Prevalence and Prescribers' Knowledge of WHO Standards for ACT Usage: A Case Study in Lagos State
Keywords:
Malaria prevalence, Artemisinin Combination Therapy, Knowledge, Guidelines, NigeriaAbstract
Malaria remains a significant public health challenge in Nigeria, consistently contributing to high morbidity rates reported in hospitals. Despite global advancements in malaria treatment, concerns persist about prescribers' adherence to the World Health Organization (WHO) guidelines for Artemisinin-based Combination Therapies (ACTs), the cornerstone of malaria management. This study aimed to assess malaria prevalence and evaluate the knowledge of prescribers in Lagos State regarding WHO standards for ACT prescriptions. The study employed a cross-sectional survey design, combining laboratory testing for malaria prevalence among 2,720 patients and a structured questionnaire to assess the knowledge of 21 prescribers. Rapid diagnostic test kits were used to confirm malaria infections, while data collected were analyzed using SPSS version 26 and presented as counts and frequencies.
Findings indicated that ACTs were the most commonly prescribed treatment for uncomplicated Plasmodium falciparum, aligning with WHO guidelines. Prescribed dosage forms included intramuscular injections, oral tablets, and pediatric suspensions. A significant proportion of prescribers (66.7%) demonstrated good knowledge of ACTs, highlighting progress in clinical awareness. However, gaps in adherence to WHO standards were also noted, underscoring the need for enhanced training and policy enforcement. This study emphasizes the importance of ongoing education for healthcare providers to ensure compliance with WHO diagnostic and treatment protocols. Improving prescriber knowledge and adherence to these guidelines is critical for reducing malaria prevalence and improving patient outcomes in Nigeria.
References
Adebowale, N. (2020). Nigeria records more deaths from other diseases than COVID-19-SGF. Nigerian Journal of Malaria Studies, 2 (8), 1-30.
Ayogu, E. E., Ugwuowo, O., Amorha, K. C., & Okonta, J. M. (2015). Evaluation of ciprofloxacin effect on the antimalarial activity of some antimalarial drugs in plasmodium berghei infected mice. International Journal of physiological Science Research, 9, 1896-1903.
Dunne, M. W., Singh, N., & Shukla, M. (2005). A multicenter study of azithromycin, alone and in combination with chloroquine, for the treatment of acute uncomplicated Plasmodium falciparum malaria in India. Journal of Infectious Diseases, 191 (10), 1582–1588.
Ekeh, H. E., & Adeniyi, J. D. (1988). Health education strategies for tropical disease control in school children. Journal of Tropical Medicine and Hygiene, 91, 55–59.
Isiko, I., Nyegenye, S., Mwesigwa, A. et al. (2024). Determinants of malaria spread among under-five children in Nigeria: results from a 2021 Nigerian malaria indicator cross-sectional survey. BMC Pediatrics, 24, 646. https://doi.org/10.1186/s12887-024-05135-w
Kar, N. P., Kumar, A., Singh, O. P., Carlton, J. M., & Nanda, N. (2014). A review of malaria transmission dynamics in forest ecosystems. Parasites and Vectors, 7, 265. doi: 10.1186/1756-3305-7-265.
Lell, B., Sovric, M., Schmid, D., Luckner, D., Herbich, K., & Long, H. Y. (2001). Effect of antipyretic drugs in children with malaria. Clinical Infectious Diseases, 32 (5), 838‐841.
Matsiegui, P. B., Missinou, M. A., Necek, M., Mavoungou, E., Issifou, S., & Lell, B. (2008). Antipyretic effect of ibuprofen in Gabonese children with uncomplicated falciparum malaria: a randomized, double‐blind, placebo‐controlled trial. Malaria Journal, 2 (7), 91.
Oche, A. O., & Aminu, M. (2012). The prevalence of malarial parasitaemia among blood donors in Ahmadu Bello University Teaching Hospital, Shika, Zaria, Nigeria. Nigerian Journal of Medicine, 21, 445–449.
Tangpukdee, N., Duangdee, C., Wilairatana, P., & Krudsood, S. (2009). Malaria diagnosis: A brief review. The Korean Journal of Parasitology, 47(2), 93–102. https://doi.org/10.3347/kjp.2009.47.2.93
Van-Eijk, A. M., & Terlouw, D. J. (2011). Azithromycin for treating uncomplicated malaria. Cochrane Database Systematic Review, 2, CD006688.
WHO (2006). World Health Organization Guidelines for the treatment of malaria. Geneva. ISBN 92-4-154694-8
WHO (2012). Progress and impact series: Focus on Nigeria. Geneva: World Health Organization.
WHO (2014). World malaria report 2014 by World Health Organization. Geneva.
WHO (2018). Artemisinin and artemisinin-based combination therapy resistance: Status report. Accessed on 13th January, 2021 at https://apps.who.int/iris/handle/10665/5521
Downloads
Published
Issue
Section
License
Copyright (c) 2024 O. S. Efegene, J. J. Etim, J. M. Ibu, E. I. Ekpo, C. C. Otali, O. J. Etim-John, N. N. Agbiji, I. E. Idem (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.